{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T07:30:55Z","timestamp":1764401455374},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2005,4,18]],"date-time":"2005-04-18T00:00:00Z","timestamp":1113782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,5,3]]},"abstract":"<jats:title>Summary<\/jats:title>\n               <jats:p>The immunodeficiency in Ataxia-telangiectasia (A-T) is characterised by low T and B cell counts, low levels of IgE, IgA and\/or IgG2, and especially low levels of pneumococcal antibodies. The 23-valent pneumococcal polysaccharide vaccine (PPV23) has previously been shown not to be effective in A-T, but these patients are capable of making protective antibodies to other vaccines such as diphtheria and tetanus toxin, promising effect of the seven-valent pneumococcal conjugated vaccine (PCV7).<\/jats:p>\n               <jats:p>Nine A-T patients and 25 age and sex matched controls were vaccinated with both PCV7 and PPV23, and three A-T patients were vaccinated with PCV7 only. In the A-T patients, no significant increase in pneumococcal antibody levels were observed after the single PCV7, while the subsequent PPV23 vaccination resulted in a significant increase in antibody levels to the PPV23 mix, as well as to serotype 4, 14, 19F and to the geometric mean of serotype 4, 6B, 14, 18C, 19F, 23F which increased from median 0\u00b72 (range 0\u00b71\u20130\u00b75) microg\/mL to 0\u00b76 (0\u00b72\u20131\u00b75) microg\/mL (P= 0\u00b7014). Compared to the patients\u2019 baseline levels, the vaccinations induced a 1\u00b75- to 7-fold increase in antibodies to the six different serotypes tested. The increases in pneumococcal antibody titres were lower than those observed in the controls (9- to 34-fold increase). The results are valuable in planning the care of A-T patients, using PCV7 to trigger and PPV23 to booster the immune response and possibly prevent severe pneumococcal disease.<\/jats:p>","DOI":"10.1111\/j.1365-2249.2005.02791.x","type":"journal-article","created":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T12:59:02Z","timestamp":1117630742000},"page":"507-516","source":"Crossref","is-referenced-by-count":36,"title":["Pneumococcal conjugate vaccine followed by pneumococcal polysaccharide vaccine; immunogenicity in patients with ataxia-telangiectasia"],"prefix":"10.1093","volume":"140","author":[{"given":"A","family":"Stray-Pedersen","sequence":"first","affiliation":[{"name":"Department of Paediatrics"},{"name":"Department of Medical Genetics, Rikshospitalet University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I S","family":"Aaberge","sequence":"additional","affiliation":[{"name":"The Norwegian Institute of Public Health, Oslo, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Fr\u00fch","sequence":"additional","affiliation":[{"name":"Department of Paediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T G","family":"Abrahamsen","sequence":"additional","affiliation":[{"name":"Department of Paediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2005,4,18]]},"reference":[{"key":"2022010818035428200_b1","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/336577a0","article-title":"Localization of an ataxia-telangiectasia gene to chromosome 11q22\u201323","volume":"336","author":"Gatti","year":"1988","journal-title":"Nature"},{"key":"2022010818035428200_b2","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1126\/science.7792600","article-title":"A single ataxia telangiectasia gene with a product similar to PI-3 kinase","volume":"268","author":"Savitsky","year":"1995","journal-title":"Science"},{"key":"2022010818035428200_b3","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1046\/j.1365-2249.2002.01830.x","article-title":"Deficiencies in CD4+ and CD8+ T cell subsets in ataxia telangiectasia","volume":"129","author":"Schubert","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"2022010818035428200_b4","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1365-2249.2004.02492.x","article-title":"The impact of an early truncating founder ATM mutation on immunoglobulins, specific antibodies and lymphocyte populations in ataxia-telangiectasia patients and their parents","volume":"137","author":"Stray-Pedersen","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"2022010818035428200_b5","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0165-5876(02)00068-X","article-title":"Deficient IgA and IgG2 anti-pneumococcal antibody levels and response to vaccination in otitis prone children","volume":"64","author":"Dhooge","year":"2002","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"2022010818035428200_b6","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1023\/A:1020599810261","article-title":"Impaired IgG antibody production to pneumococcal polysaccharides in patients with ataxia-telangiectasia","volume":"19","author":"Sanal","year":"1999","journal-title":"J Clin Immunol"},{"key":"2022010818035428200_b7","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00006454-200003000-00003","article-title":"Efficacy, safety and immunogenicity og heptavalent pneumococcal conjugate vaccine in children","volume":"19","author":"Black","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"2022010818035428200_b8","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1097\/00006454-200009000-00009","article-title":"Immunogenicity and reactogenicity of a pneumococcal conjugate vaccine administered combined with a Haemophilus influenzae type b conjugate vaccine in United Kingdom infants","volume":"19","author":"Choo","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"2022010818035428200_b9","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1086\/422651","article-title":"Nasopharyngeal pneumococcal carriage after combined pneumococcal conjugate and polysaccharide vaccination in children with a history of recurrent acute otitis media","volume":"39","author":"Veenhoven","year":"2004","journal-title":"Clin Infect Dis"},{"key":"2022010818035428200_b10","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1016\/S0140-6736(03)13772-5","article-title":"Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomised study","volume":"361","author":"Veenhoven","year":"2003","journal-title":"Lancet"},{"key":"2022010818035428200_b11","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1046\/j.1365-2249.1996.d01-728.x","article-title":"Human antibody response to a pneumococcal vaccine in SCID-PBL-hu mice and simultaneously vaccinated human cell donors","volume":"105","author":"Aaberge","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"2022010818035428200_b12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0022-1759(96)00033-6","article-title":"Simple determination of polysaccharide specific antibodies by means of chemically modified ELISA plates","volume":"193","author":"Zielen","year":"2004","journal-title":"J Immunol Meth"},{"key":"2022010818035428200_b13","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/sj.bmt.1703228","article-title":"Humoral immunity to viral and bacterial antigens in lymphoma patients 4\u201310 years after high-dose therapy with ABMT. Serological responses to revaccinations according to EBMT guidelines","volume":"28","author":"Nordoy","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"2022010818035428200_b14","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.1469-0691.1999.tb00420.x","article-title":"Detection of diphtheria antitoxin by four different methods","volume":"5","author":"Skogen","year":"1999","journal-title":"Clin Microbiol Infect"},{"key":"2022010818035428200_b15","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0092-1157(87)90037-0","article-title":"Modification of the ELISA for the estimation of tetanus antitoxin in human sera","volume":"15","author":"Simonsen","year":"1987","journal-title":"J Biol Stand"},{"key":"2022010818035428200_b16","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1023\/B:JOCI.0000029109.15355.ba","article-title":"Antibody response to a seven-valent pneumococcal conjugated vaccine in patients with ataxia-telangiectasia","volume":"24","author":"Sanal","year":"2004","journal-title":"J Clin Immunol"},{"key":"2022010818035428200_b17","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/01.inf.0000115737.35353.55","article-title":"Immunogenicity of the seven valent pneumococcal conjugate vaccine in patients with ataxia-telangiectasia","volume":"23","author":"Schubert","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"2022010818035428200_b18","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1002\/(SICI)1521-4141(200004)30:4<1214::AID-IMMU1214>3.0.CO;2-D","article-title":"Immunogenetic analysis of the immune response to pneumococcal polysaccharide","volume":"30","author":"Baxendale","year":"2000","journal-title":"Eur J Immunol"},{"key":"2022010818035428200_b19","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(02)08516-1","article-title":"MBL genotype and risk of invasive pneumococcal disease: a case-control study","volume":"359","author":"Roy","year":"2002","journal-title":"Lancet"},{"key":"2022010818035428200_b20","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1086\/340216","article-title":"Variant mannose-binding lectin alleles are not associated with susceptibility to or outcome of invasive pneumococcal infection in randomly included patients","volume":"185","author":"Kronborg","year":"2002","journal-title":"J Infect Dis"},{"key":"2022010818035428200_b21","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/S0140-6736(02)11223-2","article-title":"Mannose-binding lectin genotype as a risk factor for invasive pneumococcal infection","volume":"360","author":"Kronborg","year":"2002","journal-title":"Lancet"},{"key":"2022010818035428200_b22","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1046\/j.1365-2249.2001.01518.x","article-title":"Direct B\/B\u2013cell interactions in immunoglobulin synthesis","volume":"124","author":"Shinozaki","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"2022010818035428200_b23","doi-asserted-by":"crossref","first-page":"4083","DOI":"10.1128\/IAI.70.8.4083-4091.2002","article-title":"Recurrent variable region gene usage and somatic mutation in the human antibody response to the capsular polysaccharide of Streptococcus pneumoniae type 23F","volume":"70","author":"Zhou","year":"2002","journal-title":"Infect Immun"},{"key":"2022010818035428200_b24","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.4049\/jimmunol.168.6.2773","article-title":"Essential role for CD40 ligand interactions in T lymphocyte-mediated modulation of the murine immune response to pneumococcal capsular polysaccharides","volume":"168","author":"Jeurissen","year":"2002","journal-title":"J Immunol"},{"key":"2022010818035428200_b25","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1002\/1521-4141(200205)32:5<1300::AID-IMMU1300>3.0.CO;2-L","article-title":"Alternative end joining during switch recombination in patients with Ataxia-Telangiectasia","volume":"32","author":"Pan","year":"2002","journal-title":"Eur J Immunol"},{"key":"2022010818035428200_b26","doi-asserted-by":"crossref","first-page":"13860","DOI":"10.1073\/pnas.241524898","article-title":"Variable deletion and duplication at recombination junction ends: implication for staggered double-strand cleavage in class-switch recombination","volume":"98","author":"Chen","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022010818035428200_b27","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0264-410X(00)00184-5","article-title":"Immunity to diphtheria and tetanus in England and Wales","volume":"19","author":"Maple","year":"2000","journal-title":"Vaccine"},{"key":"2022010818035428200_b28","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/infdis\/142.5.716","article-title":"Immunogenic correlation between cross-reacting material (CRM197) produced by a mutant of Corynebacterium diphtheriae and diphtheria toxoid","volume":"142","author":"Porro","year":"1980","journal-title":"J Infect Dis"},{"key":"2022010818035428200_b29","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0264-410X(97)00034-0","article-title":"Differences in the immunogenicity of native and formalinized cross reacting material (CRM197) of diphtheria toxin in mice and guinea pigs and their implications on the development and control of diphtheria vaccine based on CRMs","volume":"15","author":"Gupta","year":"1997","journal-title":"Vaccine"},{"key":"2022010818035428200_b30","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1080\/00365540110026502","article-title":"Low baseline antibody level to diphtheria is associated with poor response to conjugated pneumococcal vaccine in adults","volume":"33","author":"Shelly","year":"2001","journal-title":"Scand J Infect Dis"},{"key":"2022010818035428200_b31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1098-1004(1998)11:1<1::AID-HUMU1>3.0.CO;2-O","article-title":"Recommendations for a nomenclature system for human gene mutations. Nomenclature Working Group","volume":"11","author":"Antonarakis","year":"1998","journal-title":"Hum Mutat"},{"key":"2022010818035428200_b32","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1093\/hmg\/4.11.2025","article-title":"The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species","volume":"4","author":"Savitsky","year":"1995","journal-title":"Hum Mol Genet"},{"key":"2022010818035428200_b33","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1101\/gr.7.6.592","article-title":"Ataxia-telangiectasia locus: sequence analysis of 184 kb of human genomic DNA containing the entire ATM gene","volume":"7","author":"Platzer","year":"1997","journal-title":"Genome Res"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2005.02791.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/140\/3\/507\/42081366\/j.1365-2249.2005.02791.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/140\/3\/507\/42081366\/j.1365-2249.2005.02791.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,8]],"date-time":"2022-01-08T18:05:17Z","timestamp":1641665117000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/140\/3\/507\/6440502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4,18]]},"references-count":33,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2005,4,18]]},"published-print":{"date-parts":[[2005,5,3]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.2005.02791.x","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,6]]},"published":{"date-parts":[[2005,4,18]]}}}